1. Home
  2. Live Updates
  3. Wegovy ozempic

Live Breaking News & Updates on Wegovy ozempic

Stay informed with the latest breaking news from Wegovy ozempic on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Wegovy ozempic and stay connected to the pulse of your community

Why Employees May Job-Hop For Help With Weight Loss Medications

20% of Americans would change jobs to get Ozempic and/or Wegovy coverage.

United-states , American , Americans , Sethu-reddy , Angela-fitch , University-of-texas , American-association-of-clinical-endocrinology , Obesity-medicine-association , American-association , Ozempic , Wegovy , Medication-coverage

Obesity Medications And Weight Loss; 20% Job-Hop For Ozempic/Wegovy

20% of Americans would change jobs to get Ozempic and/or Wegovy coverage.

United-states , Americans , American , Sethu-reddy , Angela-fitch , American-association-of-clinical-endocrinology , Obesity-medicine-association , University-of-texas , American-association , Ozempic , Wegovy , Medication-coverage

What We're Reading: Medicare Pay Cuts; Health Insurers Covet Sicker Patients; Misbranded Weight Loss Drug Sales

Part of the recent Medicare reimbursement cuts could be addressed in a spending package next month; Medicaid/Medicare dual eligibles are expected to generate big profits for health insurers; FDA sent warning letters to online vendors selling unapproved and misbranded versions of semaglutide and tirzepatide.

Indiana , United-states , Larry-bucshon , Health-insurers-are-suddenly-coveting-sicker-patients , Physicians-lobby-congress-on-medicare-pay , Physicians-lobby-congress , Medicare-pay , What-we-x27-re-reading , Medicare-reimbursement-cuts , Medicaid , Medicare , Ozempic

Mounjaro: Weight Loss Shot Goes On Sale Privately In The U.K.

The drug was approved by the country’s drug regulator last fall for the treatment of type 2 diabetes and obesity.

London , City-of , United-kingdom , British , Eli-lilly , Novo-nordisk-ozempic , National-health-service , Health-regulatory-agency , National-institute-for-health , London-pharmacy , Simple-online-pharmacy , National-health

Forbes Daily: Earnings Show Meta's Turnaround And Apple's Tepid Growth

A major month for layoffs; How much Supreme Court Justice Ketanji Brown Jackson is worth; Trump racks up nearly $40 million in legal fees; and more

White-house , District-of-columbia , United-states , Denmark , Los-angeles , California , Miami , Florida , China , Danish , American , Chinese

Amplify: The Ozempic-shaming has been noted (and is unhelpful)

In this issue of Amplify, Brianna Bell talks about using the drug on her health journey

Canada , Oprah-winfrey , Brianna-bell , Youtube , People-magazine , Facebook , Instagram , Log-increate-free , Newsletter , Amplify , Amplify-globe-and-mail , Globe-and-mail-newsletters

How Ozempic Maker Novo Nordisk Is Tackling Weight Loss Drug Shortage This Year

The influx will mean more U.S. patients can get started on treatment, said CEO Lars Fruergaard Jorgensen.


Denmark , United-states , Austria , United-kingdom , Britain , Danish , Lars-fruergaard-jorgensen , Novo-nordisk , Forbesfake-wegovy , Drug-administration , Fruergaard-jorgensen , Wegovy

Novo Nordisk Beats Profit Forecasts As Weight-Loss Sales Soar

GLP-1 injectable drugs like Ozempic and Wegovy made up a significant portion of the company’s annual sales.


Denmark , France , Finland , French , Danish , Lars-fruergaard-jorgensen , Eli-lilly , Novo-nordisk , Nokia , Glp-1 , Mounjaro , Weight-loss

Now On The Menu: Ozempic-Type Drugs

These may be the biggest blockbuster drugs of all time. Restaurants must adapt.

Florida , United-states , New-york , Americans , Natural-marketing-association , Portion-balance-coalition , Goldman-sachs , Morgan-stanley , Georgetown-university-portion-balance-coalition , Bloomberg , Wall-street

We do a few things, but those few things must be the best in the world: Novo Nordisk's top exec

Novo Nordisk, the most valuable pharmaceutical company in the world, turned 100 last year. While it is largely known for its insulins, its anti-obesity drugs are making waves of late. Maziar Mike Doustdar, executive vice-president, international operations at Novo Nordisk tells ET Prime the beliefs that distinguish the company.

Denmark , Danish , Novo-nordisk , Novo , India , Wegovy , Sadhana-saxena ,